The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Small Molecule Targeted Cancer Therapy-Global Market Insights and Sales Trends 2025
Synopsis
Most targeted therapies are either small-molecule drugs or monoclonal antibodies. Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells. Monoclonal antibodies, also known as therapeutic antibodies, are proteins produced in the lab.
The global Small Molecule Targeted Cancer Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Small Molecule Targeted Cancer Therapy in various end use industries. The expanding demands from the Lymphoma, Melanoma, Multiple Myeloma and Breast Cancer, are propelling Small Molecule Targeted Cancer Therapy market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Small Molecules segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Small Molecule Targeted Cancer Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Small Molecule Targeted Cancer Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Small Molecule Targeted Cancer Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Small Molecule Targeted Cancer Therapy covered in this report include Roche, Gilead Sciences, Boehringer Ingelheim, Abbott Laboratories, Bayer AG, GSK, AstraZeneca, Johnson & Johnson and Teva, etc.
The global Small Molecule Targeted Cancer Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Gilead Sciences
Boehringer Ingelheim
Abbott Laboratories
Bayer AG
GSK
AstraZeneca
Johnson & Johnson
Teva
Pfizer
Allergan
Merck
Novartis
Sanofi
Amgen
AbbVie
Eli Lilly
Global Small Molecule Targeted Cancer Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Small Molecule Targeted Cancer Therapy market, Segment by Type:
Monoclonal Antibodies
Small Molecules
Small Molecule Drug Conjugates
Global Small Molecule Targeted Cancer Therapy market, by Application
Lymphoma
Melanoma
Multiple Myeloma
Breast Cancer
Prostate Cancer
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Small Molecule Targeted Cancer Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Most targeted therapies are either small-molecule drugs or monoclonal antibodies. Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells. Monoclonal antibodies, also known as therapeutic antibodies, are proteins produced in the lab.
The global Small Molecule Targeted Cancer Therapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Small Molecule Targeted Cancer Therapy in various end use industries. The expanding demands from the Lymphoma, Melanoma, Multiple Myeloma and Breast Cancer, are propelling Small Molecule Targeted Cancer Therapy market. Monoclonal Antibodies, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Small Molecules segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion US$ in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion US$ in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Small Molecule Targeted Cancer Therapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Small Molecule Targeted Cancer Therapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Small Molecule Targeted Cancer Therapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Small Molecule Targeted Cancer Therapy covered in this report include Roche, Gilead Sciences, Boehringer Ingelheim, Abbott Laboratories, Bayer AG, GSK, AstraZeneca, Johnson & Johnson and Teva, etc.
The global Small Molecule Targeted Cancer Therapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Roche
Gilead Sciences
Boehringer Ingelheim
Abbott Laboratories
Bayer AG
GSK
AstraZeneca
Johnson & Johnson
Teva
Pfizer
Allergan
Merck
Novartis
Sanofi
Amgen
AbbVie
Eli Lilly
Global Small Molecule Targeted Cancer Therapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Small Molecule Targeted Cancer Therapy market, Segment by Type:
Monoclonal Antibodies
Small Molecules
Small Molecule Drug Conjugates
Global Small Molecule Targeted Cancer Therapy market, by Application
Lymphoma
Melanoma
Multiple Myeloma
Breast Cancer
Prostate Cancer
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Small Molecule Targeted Cancer Therapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Small Molecule Targeted Cancer Therapy
1.1 Small Molecule Targeted Cancer Therapy Market Overview
1.1.1 Small Molecule Targeted Cancer Therapy Product Scope
1.1.2 Small Molecule Targeted Cancer Therapy Market Status and Outlook
1.2 Global Small Molecule Targeted Cancer Therapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Small Molecule Targeted Cancer Therapy Market Size by Region (2018-2029)
1.4 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Region (2018-2023)
1.5 Global Small Molecule Targeted Cancer Therapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Small Molecule Targeted Cancer Therapy Market Size (2018-2029)
1.6.1 North America Small Molecule Targeted Cancer Therapy Market Size (2018-2029)
1.6.2 Europe Small Molecule Targeted Cancer Therapy Market Size (2018-2029)
1.6.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size (2018-2029)
1.6.4 Latin America Small Molecule Targeted Cancer Therapy Market Size (2018-2029)
1.6.5 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size (2018-2029)
2 Small Molecule Targeted Cancer Therapy Market by Type
2.1 Introduction
2.1.1 Monoclonal Antibodies
2.1.2 Small Molecules
2.1.3 Small Molecule Drug Conjugates
2.2 Global Small Molecule Targeted Cancer Therapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Type (2018-2023)
2.2.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Small Molecule Targeted Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Small Molecule Targeted Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Small Molecule Targeted Cancer Therapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Breakdown by Type (2018-2029)
3 Small Molecule Targeted Cancer Therapy Market Overview by Application
3.1 Introduction
3.1.1 Lymphoma
3.1.2 Melanoma
3.1.3 Multiple Myeloma
3.1.4 Breast Cancer
3.1.5 Prostate Cancer
3.1.6 Others
3.2 Global Small Molecule Targeted Cancer Therapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Small Molecule Targeted Cancer Therapy Historic Market Size by Application (2018-2023)
3.2.2 Global Small Molecule Targeted Cancer Therapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Small Molecule Targeted Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Small Molecule Targeted Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Small Molecule Targeted Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Small Molecule Targeted Cancer Therapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Small Molecule Targeted Cancer Therapy Revenue Breakdown by Application (2018-2029)
4 Small Molecule Targeted Cancer Therapy Competition Analysis by Players
4.1 Global Small Molecule Targeted Cancer Therapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Small Molecule Targeted Cancer Therapy as of 2022)
4.3 Date of Key Players Enter into Small Molecule Targeted Cancer Therapy Market
4.4 Global Top Players Small Molecule Targeted Cancer Therapy Headquarters and Area Served
4.5 Key Players Small Molecule Targeted Cancer Therapy Product Solution and Service
4.6 Competitive Status
4.6.1 Small Molecule Targeted Cancer Therapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche
5.1.1 Roche Profile
5.1.2 Roche Main Business
5.1.3 Roche Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.1.4 Roche Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.1.5 Roche Recent Developments
5.2 Gilead Sciences
5.2.1 Gilead Sciences Profile
5.2.2 Gilead Sciences Main Business
5.2.3 Gilead Sciences Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.2.4 Gilead Sciences Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.2.5 Gilead Sciences Recent Developments
5.3 Boehringer Ingelheim
5.3.1 Boehringer Ingelheim Profile
5.3.2 Boehringer Ingelheim Main Business
5.3.3 Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.3.4 Boehringer Ingelheim Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Laboratories Recent Developments
5.4 Abbott Laboratories
5.4.1 Abbott Laboratories Profile
5.4.2 Abbott Laboratories Main Business
5.4.3 Abbott Laboratories Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.4.4 Abbott Laboratories Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Laboratories Recent Developments
5.5 Bayer AG
5.5.1 Bayer AG Profile
5.5.2 Bayer AG Main Business
5.5.3 Bayer AG Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.5.4 Bayer AG Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer AG Recent Developments
5.6 GSK
5.6.1 GSK Profile
5.6.2 GSK Main Business
5.6.3 GSK Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.6.4 GSK Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.6.5 GSK Recent Developments
5.7 AstraZeneca
5.7.1 AstraZeneca Profile
5.7.2 AstraZeneca Main Business
5.7.3 AstraZeneca Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.7.4 AstraZeneca Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.7.5 AstraZeneca Recent Developments
5.8 Johnson & Johnson
5.8.1 Johnson & Johnson Profile
5.8.2 Johnson & Johnson Main Business
5.8.3 Johnson & Johnson Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.8.4 Johnson & Johnson Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.8.5 Johnson & Johnson Recent Developments
5.9 Teva
5.9.1 Teva Profile
5.9.2 Teva Main Business
5.9.3 Teva Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.9.4 Teva Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.9.5 Teva Recent Developments
5.10 Pfizer
5.10.1 Pfizer Profile
5.10.2 Pfizer Main Business
5.10.3 Pfizer Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.10.4 Pfizer Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.10.5 Pfizer Recent Developments
5.11 Allergan
5.11.1 Allergan Profile
5.11.2 Allergan Main Business
5.11.3 Allergan Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.11.4 Allergan Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.11.5 Allergan Recent Developments
5.12 Merck
5.12.1 Merck Profile
5.12.2 Merck Main Business
5.12.3 Merck Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.12.4 Merck Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.12.5 Merck Recent Developments
5.13 Novartis
5.13.1 Novartis Profile
5.13.2 Novartis Main Business
5.13.3 Novartis Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.13.4 Novartis Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.13.5 Novartis Recent Developments
5.14 Sanofi
5.14.1 Sanofi Profile
5.14.2 Sanofi Main Business
5.14.3 Sanofi Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.14.4 Sanofi Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.14.5 Sanofi Recent Developments
5.15 Amgen
5.15.1 Amgen Profile
5.15.2 Amgen Main Business
5.15.3 Amgen Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.15.4 Amgen Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.15.5 Amgen Recent Developments
5.16 AbbVie
5.16.1 AbbVie Profile
5.16.2 AbbVie Main Business
5.16.3 AbbVie Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.16.4 AbbVie Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.16.5 AbbVie Recent Developments
5.17 Eli Lilly
5.17.1 Eli Lilly Profile
5.17.2 Eli Lilly Main Business
5.17.3 Eli Lilly Small Molecule Targeted Cancer Therapy Products, Services and Solutions
5.17.4 Eli Lilly Small Molecule Targeted Cancer Therapy Revenue (US$ Million) & (2018-2023)
5.17.5 Eli Lilly Recent Developments
6 North America
6.1 North America Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Targeted Cancer Therapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Targeted Cancer Therapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Small Molecule Targeted Cancer Therapy Market Dynamics
11.1 Small Molecule Targeted Cancer Therapy Industry Trends
11.2 Small Molecule Targeted Cancer Therapy Market Drivers
11.3 Small Molecule Targeted Cancer Therapy Market Challenges
11.4 Small Molecule Targeted Cancer Therapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
